A total of 16 patients with genetically confirmed SPG11-HSP were recruited, including 8 females and 8 males, with an equal distribution of early, intermediate, and late disease stages (Table 1 and Table 2). The gene discussed is SPG11; the disease is hereditary spastic paraplegia.